Vectura Group Company News

Epic Code:
Sub Sector:
Market Cap:

ORD GBP0.00025
Pharmaceuticals & Biotechnology
UK Main Market
269.02594229 GBPm

Data as of 10:00 23/09/2009. Check director details and other company announcments at Vectura Group Website .

RNS News for Vectura Group

Regulatory News Service : RNS provides a service that enables local or international listed companies to meet company news reporting obligations in UK, Europe and US - international filings use different processes: Provides investors & professionals equal access to new company information as it is released. For further details of RNS news see London Stock Exchange website.

Latest Vectura Group News

Vectura Group to hook up with Dynavax to develop cancer treatment
Proactive Investors UK - Aug 16, 2017
The collaboration will see Vectura's AKITA smart nebuliser used by Dynavax to deliver DV281, a protein that triggers an immunity response, designed specifically for local delivery to primary lung tumours.
Vectura Signs Exclusive Development Deal On Lung Cancer With Dynavax - London South East (registration) (blog)
Vectura's AKITA Nebuliser To Be Used By Dynavax For Lung Cancer Programme - Nasdaq

08/16/2017 10:16 AM

Vectura reports wider loss but revenue jumps after Skyepharma merger
Proactive Investors UK - Mar 21, 2017
Respiratory medicines maker Vectura Group PLC (LON:VEC) posted a wider loss for the nine months to the end of 2016, reflecting charges related to its £441mln merger with Skyepharma.

03/21/2017 07:43 AM

Will Vectura Group plc outperform AstraZeneca plc after today's results gain a ...
Motley Fool UK - Jan 11, 2017
Inhaled airways disease specialist Vectura (LSE: VEC) has released an impressive update today. It shows that the company has made good progress in the first nine months of the year and has the potential to deliver improved performance in future.

01/11/2017 12:22 PM

Vectura Group plc: Pre-close update
GlobeNewswire (press release) - Jan 11, 2017
Chippenham, UK - 11 January 2017: Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading device and formulation business for inhaled airways disease, today announces an unaudited pre-close update ahead of its results for the nine ...

01/11/2017 07:07 AM

Could Vectura Group plc grow to be a FTSE 100 company within 10 years?
Motley Fool UK - Nov 23, 2016
Respiratory drugs and devices specialist Vectura (LSE: VEC) today released its first results since completing a merger with Skyepharma in June.

11/23/2016 03:45 PM

This unfancied drug stock has the potential to soar
Proactive Investors UK - Sep 7, 2016
They've been rewarded with an 11% rise in the share price post-results. But it has been a hard slog for investors in respiratory specialist Vectura Group PLC (LON:VEC), who have seen the stock drift by around a quarter over the last year. The reason ...
Why Vectura group plc and GlaxoSmithKline plc could be the perfect combination - Motley Fool UK

09/07/2016 03:03 PM